🔎 Trials Near Me

Akèy › Gliyoblastòm › Texas › San Antonio

Etid klinik pou Gliyoblastòm nan San Antonio, TX

8 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote San Antonio (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Ap rekriteFaz 1/2
  • START | San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06914128

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • University of Texas Health Mays Cancer Center, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Ap rekriteFaz 2
  • The University of Texas Health Science Center at San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT06805305

Sacituzumab Govitecan in Recurrent Glioblastoma

Ap rekriteFaz 2
  • University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT04559230

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

Ap rekriteFaz 2
  • Mays Cancer Center, UT Health San Antonio, San Antonio
Tout laj · Tout sèks · Mizajou Aug 27, 2025 · NCT04863950

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Ap rekriteFaz 1
  • The Cancer Therapy and Research Center at UTHSCSA, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2025 · NCT05460507

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Ap rekriteFaz 1/2
  • The Cancer Therapy and Research Center at UTHSCSA, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT01906385

Etid Gliyoblastòm nan lòt vil

Lòt etid nan San Antonio

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.